日本医療と世界を繋ぐ架け橋
株式会社ポラリスRXについて

We are an R&D oriented company with special focus on advanced medicinal products. We are committed to bring value to patients through the excellence in product development activity. Our lead product is cellular cartilage regeneration for osteoarthritis and knee injuries. We also provide a service to help patients receive gene therapy in foreign countries.

 


About "Cell Therapy for Osteoarthritis & Sport Injury"

About "Gene Therapy"
最新のニュース
2010   Feb

2009   Dec
 
Nov
Jul
Jul
 
Apr
2008   Nov
Oct
Jul
Mar
2007   Aug
Jul
Jun
 
Gene therapy initiative started

PRX-004 project out-licensed

 

"Red Herring 100 Asia Company" prize awarded by Red Herring
Fulfilled the requirement for the revised Angel Investment Law for the year 2009
Featured at a booklet of Ministry of Economy, Trade and Industry
 
"MINATO 10” grant awarded
PRX-003 project designated as one of Super-Tokku Projects by Cabinet Office of the Japanese government
"Venture Promotion Grant" awarded
Comformity Assessment dossier of PRX-003 submitted
  
NerveTube in-licensed from Kyoto University
Grand Prize awarded at the 7th MIT Business Contest
Head Office moved to Kobe, Japan
Cellular therapy for cartilage regeneration in-licenced from Germany